AR029687A1 - Composiciones y metodos para el manejo del peso corporal - Google Patents

Composiciones y metodos para el manejo del peso corporal

Info

Publication number
AR029687A1
AR029687A1 ARP010103006A ARP010103006A AR029687A1 AR 029687 A1 AR029687 A1 AR 029687A1 AR P010103006 A ARP010103006 A AR P010103006A AR P010103006 A ARP010103006 A AR P010103006A AR 029687 A1 AR029687 A1 AR 029687A1
Authority
AR
Argentina
Prior art keywords
carbon atoms
body weight
satiety
reduce
carbon
Prior art date
Application number
ARP010103006A
Other languages
English (en)
Inventor
Ronald James Jandacek
Gary Robert Kelm
Satinder Singh Bharaj
Jorge Villanueva Penafiel
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR029687A1 publication Critical patent/AR029687A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/40—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the fats used
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

Se refiere a métodos para ayudar a sujetos a reducir la cantidad consumida de alimentos, que se menciona como la absorcion de energía, de forma de manejar el peso corporal. Estos métodos incluyen el uso de agentes para actuar en el sistema nervioso central para aumentar los niveles de serotonina, y aquellos que actuan en el tracto intestinal para reducir la digestion y/o absorcion de nutrientes, y que adolecen de efectos secundarios potenciales que reducen su utilidad para el manejo a largo plazo del peso corporal. Una composicion oral que induce de saciedad en humanos y animales que comprende agentes de saciedad seleccionados del grupo que consiste de ácidos grasos de cadena larga, sus ésteres que no contienen glicerilo, hidrolizables en presencia de enzimas gastrointestinales, y mezclas de estos en donde dicho agente de saciedad se libera en el estomago. Dicha composicion en donde dichos ácidos grasos de cadena larga y sus ésteres que no contienen glicerilo contienen de 12 a 24 átomos de carbono, con 0 a 6 enlaces dobles de átomos carbono-carbono; alternativamente 16 a 18 átomos de carbono con 0 a 3 enlaces dobles de átomos carbono-carbono.
ARP010103006A 2000-06-26 2001-06-25 Composiciones y metodos para el manejo del peso corporal AR029687A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/603,626 US7025984B1 (en) 2000-06-26 2000-06-26 Compositions and methods for body weight management

Publications (1)

Publication Number Publication Date
AR029687A1 true AR029687A1 (es) 2003-07-10

Family

ID=24416242

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103006A AR029687A1 (es) 2000-06-26 2001-06-25 Composiciones y metodos para el manejo del peso corporal

Country Status (17)

Country Link
US (2) US7025984B1 (es)
EP (2) EP1676488A3 (es)
JP (2) JP2004501170A (es)
CN (1) CN100334973C (es)
AR (1) AR029687A1 (es)
AT (1) ATE324053T1 (es)
AU (1) AU2001268644A1 (es)
BR (1) BR0111963A (es)
CA (1) CA2410985C (es)
DE (1) DE60119104T2 (es)
MX (1) MXPA03000048A (es)
NZ (1) NZ522996A (es)
PE (1) PE20020112A1 (es)
PL (1) PL202686B1 (es)
RU (1) RU2301668C2 (es)
WO (1) WO2002000042A2 (es)
ZA (1) ZA200209662B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7025984B1 (en) * 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
DE10044846A1 (de) * 2000-09-11 2002-04-04 Guenther Beisel Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung
WO2003082240A1 (de) * 2002-03-30 2003-10-09 Beisel Guenther Zubereitung enthaltend fettsäure zur appetitminderung, sättigung und/oder gewichtsreduktion
US7393552B2 (en) 2002-04-24 2008-07-01 The Procter & Gamble Company Compositions comprising protein and fatty acid
US20030203004A1 (en) * 2002-04-24 2003-10-30 Kelm Gary Robert Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight
US20030203097A1 (en) * 2002-04-24 2003-10-30 The Procter & Gamble Company Acidic compositions comprising protein and fiber and processes of their preparation
US20030203042A1 (en) * 2002-04-24 2003-10-30 Cook Lisa Ann Compositions comprising milk protein concentrate and fatty acid and processes of their preparation
TW200412942A (en) * 2002-08-06 2004-08-01 Abbott Lab Appetite control method
US20040044079A1 (en) * 2002-09-04 2004-03-04 The Iams Company Methods and compositions for weight control
AU2003300531A1 (en) * 2002-12-19 2004-07-29 Gunther Beisel Substance for creating a saturation effect and reducing weight in animals
AU2003294816A1 (en) * 2002-12-19 2004-07-14 Gunther Beisel Preparation for reducing the appetite, producing a satiated feeling and/or for weight loss in children
SE0203886D0 (sv) * 2002-12-27 2002-12-27 Ltp Lipid Technologies Provide Glycerolesterprodukt och dess användning
ES2229935B1 (es) * 2003-10-10 2006-10-01 Universitat De Les Illes Balears Utilizacion del acido hidroxioleico y compuestos analagos del mismo como aditivos alimentarios funcionales.
WO2005063230A1 (en) * 2003-12-30 2005-07-14 Universite Laval Use of conjugated linolenic acids for reducing body fat mass
KR100756890B1 (ko) * 2005-08-19 2007-09-07 경희대학교 산학협력단 신경세포 보호활성을 갖는 올레산을 함유하는 조성물
WO2007047596A1 (en) * 2005-10-17 2007-04-26 Hill's Pet Nutrition, Inc. Methods for reducing food intake and decreasing appetite in animals
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
US9066915B2 (en) * 2006-10-03 2015-06-30 Michael D. Myers Meal replacement compositions and weight control method
US20080220104A1 (en) * 2007-03-08 2008-09-11 Cappello John V Compositions for producing satiety
EP2134195B1 (de) * 2008-03-05 2011-11-02 B.R.A.I.N. Biotechnology Research And Information Network AG Verfahren zur geschmacksmodulation von stofflichen zusammensetzungen, die mindestens einen high intensity sweetener (his) enthalten
US9239334B2 (en) * 2008-09-08 2016-01-19 President And Fellows Of Harvard College Fatty acid C16: 1N7-palmitoleate a lipokine and biomarker for metabolic status
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
EP2413925A1 (en) 2009-04-03 2012-02-08 DSM IP Assets B.V. Satiety-inducing composition
US10058117B2 (en) * 2009-11-23 2018-08-28 Randall Scott Hickle Dietary health food composition, package and method of use
CN101822662B (zh) * 2010-04-30 2011-06-08 中国人民解放军总医院 9,10-二羟基硬脂酸(dhsa)在制备防治糖尿病药物中的用途
BR112013015492A2 (pt) * 2010-12-20 2016-07-19 Hills Pet Nutrition Inc composições de ração para animais de estimação para induzir uma resposta de saciedade
WO2013132092A1 (en) 2012-03-09 2013-09-12 Pensieve International Plc Use of monounsaturated fatty acid compounds for controlling the body weight of a dog or a cat
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
CN104902887B (zh) * 2012-10-29 2019-05-17 国立大学法人京都大学 包含稀有脂肪酸的代谢改善剂
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
MA41611A (fr) * 2015-02-23 2018-01-02 Omthera Pharmaceuticals Inc Préparations en milli-capsules comprenant des acides gras polyinsaturés libres
EP3574899A1 (en) * 2018-05-28 2019-12-04 Université de Bourgogne Oleic acid derivatives, pharmaceutical composition or food composition comprising said oleic acid derivatives, and their uses
KR102087634B1 (ko) * 2018-10-11 2020-03-11 (주)바이텍 항비만용 조성물
US20220347144A1 (en) * 2019-09-27 2022-11-03 University Of Virginia Patent Foundation Compositions and methods for preventing and/or reducing weight gain and associated conditions
CN115429815B (zh) * 2021-06-02 2023-12-22 广州帝奇医药技术有限公司 一种长效饱腹组合物、制备方法及用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
US4298601A (en) 1972-03-06 1981-11-03 Technutra, S.A. Method and formulations for the treatment of obesity
US3865939A (en) * 1973-02-23 1975-02-11 Procter & Gamble Edible oils having hypocholesterolemic properties
IE47777B1 (en) 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
CH636013A5 (en) * 1978-03-07 1983-05-13 Sandoz Ag More readily absorbable pharmaceutical composition
SE8505569D0 (sv) 1985-11-25 1985-11-25 Aco Laekemedel Ab Enteralt preparat
GB8603171D0 (en) * 1986-02-08 1986-03-12 Howard A N Dietary product
JPH0699321B2 (ja) 1990-01-22 1994-12-07 不二製油株式会社 食欲抑制剤及びこれを含有する食品
US5665384A (en) 1990-04-06 1997-09-09 Rhone-Poulenc Rorer S.A. Oily capsules of ketoprofen
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
DE4133694C2 (de) 1991-10-11 1993-10-07 Fresenius Ag Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen
US5322697A (en) 1992-05-28 1994-06-21 Meyer James H Composition and method for inducing satiety
JP3244586B2 (ja) * 1994-03-23 2002-01-07 キユーピー株式会社 卵白組成物及びそれを利用した食品添加用卵白組成物
JPH08140587A (ja) * 1994-11-18 1996-06-04 Lion Corp ペットフード
CA2220451A1 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Methods and compositions for improving digestion and absorption in the small intestine
ATE235505T1 (de) 1995-10-30 2003-04-15 Oleoyl Estrone Developments S Oleat monoester von estrogenen zur behandlung von fettleibigkeit
SE9702630D0 (sv) * 1997-07-07 1997-07-07 Scotia Lipidteknik Ab Satiety product
US5977195A (en) 1997-08-01 1999-11-02 Huntsman Corporation Expandable thermoplastic polymer particles and method for making same
US6054480A (en) 1997-09-18 2000-04-25 Nectra, Inc. Fatty acids as a diet supplement
JPH11209279A (ja) 1998-01-05 1999-08-03 Natural Ltd As 体重減少および肥満処置の方法
MX228618B (es) 1998-05-04 2005-06-21 Conlinco Inc Metodos para utilizar composiciones de acido linoleico conjugado enriquecidas por isomeros.
JP2000014330A (ja) * 1998-07-06 2000-01-18 Emyubaachika Japan Kk エミュオイル加工食品
AU4176200A (en) 1999-03-26 2000-10-16 Wistar Institute, The Novel genetic suppressor elements and methods of making the same
GB2355382A (en) 1999-08-24 2001-04-25 Gilbertson & Page Ltd Conjugated linoleic acid for weight reduction in a dog
ITMI991894A1 (it) 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
US6210702B1 (en) * 1999-09-13 2001-04-03 Ratib Al Samman Weight loss composition and method for losing weight
US6207638B1 (en) 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US7025984B1 (en) * 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
US6626644B2 (en) * 2000-10-30 2003-09-30 Ntn Corporation Magnetically levitated pump and controlling circuit
US6429190B1 (en) 2000-12-15 2002-08-06 Pacifichealth Laboratories, Inc. Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
US7225486B2 (en) * 2005-01-10 2007-06-05 Jackson Iii Avery M Therapeutic seat cushion

Also Published As

Publication number Publication date
CN100334973C (zh) 2007-09-05
ATE324053T1 (de) 2006-05-15
JP2004501170A (ja) 2004-01-15
NZ522996A (en) 2004-10-29
PE20020112A1 (es) 2002-03-14
CA2410985A1 (en) 2002-01-03
EP1676488A2 (en) 2006-07-05
DE60119104T2 (de) 2006-11-30
US8287898B2 (en) 2012-10-16
BR0111963A (pt) 2003-05-13
PL202686B1 (pl) 2009-07-31
JP2009132684A (ja) 2009-06-18
WO2002000042A3 (en) 2002-04-04
WO2002000042A2 (en) 2002-01-03
MXPA03000048A (es) 2004-07-08
US7025984B1 (en) 2006-04-11
CN1452461A (zh) 2003-10-29
EP1294240B1 (en) 2006-04-26
EP1294240A2 (en) 2003-03-26
AU2001268644A1 (en) 2002-01-08
EP1676488A3 (en) 2013-02-20
DE60119104D1 (de) 2006-06-01
CA2410985C (en) 2008-04-15
US20050197395A1 (en) 2005-09-08
RU2301668C2 (ru) 2007-06-27
ZA200209662B (en) 2003-10-23
PL360185A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
AR029687A1 (es) Composiciones y metodos para el manejo del peso corporal
AR025599A1 (es) Metodo para mejorar la piel y el pelaje de mascotas
AR117404A2 (es) Unidad de dosificación que comprende un análogo de prostaglandina para el tratamiento de la constipación
CL2008002910A1 (es) Composicion base para un desodorante tipo barra que comprende entre 20 y 70% en peso de propilenglicol, 5 a 60% de glicerina, 10 a 35% de agua y un agente espesante; metodo para inhibir el crecimiento bacteriano.
AR067971A1 (es) Uso de composicion para la prevencion y/o tratamiento de desordenes metabolicos
CO5111023A1 (es) Composicion de articulo absorbente y metodo para usarla para secuestrar irritantes de la piel
MX9300977A (es) Compuetos heterobiciclicos.
AR052472A1 (es) Lactobacilos probioticos para felinos
BR112012026223A2 (pt) formulação adequada para o uso em ração animal, uso, e ração para animais.
JP2012507505A5 (es)
AR022224A1 (es) Gen de la desaturasa humana y usos del mismo
SV2009002832A (es) 1h imidazopiridinas sustituidas con hidroxi y procedimientos
PE88699A1 (es) Formas de dosificacion de liberacion sostenida de sertralina
CL2011002276A1 (es) Uso de una composicion que comprende monogliceridos de acidos organicos c1 a c7 y glicerol para preparar un medicamento antibacteriano y anti-moho; uso de dicha composicion para tratar cereales, forrajes, alimento y agua potable proyectada para la alimentacion de animales.
PE20121347A1 (es) Gel blando adhesivo para tratar aves de corral
ATE386508T1 (de) Feste orale dosierungsform enthaltend einen resorptionsverstärker
AR028331A1 (es) Formula para bebes que contiene acidos grasos poli-insaturados de cadena larga y sus usos
CO6351747A2 (es) Composicion nutricional para promover desarrollo y crecimiento saludables
BRPI0713377A2 (pt) formulação nutritiva, e, uso de uma formulação
AR047065A1 (es) Bifidobacterium pseudolongum probioticas de caninos y uso
AR068697A1 (es) Composicion alimenticia para animales que comprende cascara de nuez
AR084059A1 (es) Composicion para el cuidado de telas
ECSP045124A (es) Composiciones polimeras de liberacion controlada de compuestos que promueven el crecimiento oseo
EA199900303A2 (ru) Замещенные трициклические соединения
ES2162586B1 (es) Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario

Legal Events

Date Code Title Description
FB Suspension of granting procedure